...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Question for the experts

Toinv

 

IMO, Zenith is going to have to wait til they get the Nut carcinoma trial approved with the FDA before a BP deal comes in. As mentioned in the Emerging growth conference call DM said a fast track application will be sent in this month and then a 2 month wait for a fast track approval so we won't hear about til Q12025.  I don't think we can talk Investment banks and deal til an FDA approaveddrug for the Nut carcinoma. i may wrong but why need $ 8 usd million now if a deal is that close

Share
New Message
Please login to post a reply